|
Behavioral Economics: Fundamentals and Implications for Intervention in ASD |
Monday, May 25, 2015 |
10:00 AM–10:50 AM |
Grand Ballroom C3 (CC) |
Area: AUT; Domain: Applied Research |
BACB CE Offered. CE Instructor: Jennifer N. Fritz, Ph.D. |
Chair: Jennifer N. Fritz (University of Houston-Clear Lake) |
Presenting Authors: : ISER GUILLERMO DELEON (University of Florida) |
Abstract: Behavioral economics is a productive blend of behavioral principles and micro-economic theory. Behavioral economic research has revealed that the concepts, principles, and methods that economists conventionally apply to decision-making at the population level have important parallels at the individual level. Armed with this understanding, behavior analysts gain a variety of useful analytic tools with potential for enhancing instructional and therapeutic arrangements. In this tutorial, Dr. IserGuillermo DeLeon will describe some basic tenets of behavioral economics, what one needs minimally to grasp its relevance for practice. He will then review and discuss studies, some from the behavior analytic literature and some from his own work, that show how these tools have been used to enhance our understanding of functional relations and improve our outcomes in work with people with autism spectrum disorder.
|
Instruction Level: Basic |
Target Audience: BCBAs, BCaBAs |
Learning Objectives:
- Participants will be able to explain basic behavioral economic concepts that include the law of demand, demand elasticity, substitutability, complementarity, and the impact of open vs. closed economies.
- Participants will be able to discuss how these concepts map onto common behavioral interventions to address the instructional or therapeutic needs of persons with ASD.
- Participants will understand what demand curves can offer beyond more conventional methods of gauging relative reinforcer effectiveness.
|
|
ISER GUILLERMO DELEON (University of Florida) |
Dr. Iser Guillermo DeLeon received his Ph.D. in psychology from the University of Florida in 1997 and previously held appointments at the Kennedy Krieger Institute, Johns Hopkins University School of Medicine, and the University of Maryland, Baltimore County. Currently, he is an associate professor at the University of Florida and serves on the Board of Directors of the Behavior Analysis Certification Board. Prior commitments include associate editor for the Journal of Applied Behavior Analysis, president of the Maryland Association for Behavior Analysis, and member of the Science Board of the Association for Behavior Analysis International. Dr. DeLeon's research has focused on the variables that give rise to severe behavior problems in individuals with developmental disabilities and the hypothesis-driven development of interventions for behavior disorders. Separate, often related, lines of research examine choice and determinants of stimulus value in individuals with developmental disabilities. Dr. DeLeon has been the principal investigator or co-investigator for several National Institutes of Health-funded grants, largely translational in nature, that explore the applied implications of basic behavioral processes and related theories (e.g. behavioral economics, behavioral momentum). |
|
|
|
|
Psychedelics as Adjunct Medications in Behavioral Treatments of Addiction |
Monday, May 25, 2015 |
10:00 AM–10:50 AM |
006AB (CC) |
Area: BPH/CBM; Domain: Basic Research |
PSY/BACB CE Offered. CE Instructor: Matthew W. Johnson, Ph.D. |
Chair: Paul L. Soto (Texas Tech University) |
Presenting Authors: : MATTHEW W. JOHNSON (Johns Hopkins University School of Medicine) |
Abstract: Converging evidence suggests that 5-HT2AR agonist psychedelics (classic hallucinogens) may hold a future in addiction treatment. Observational studies have reported addiction recovery associated with the ceremonial use of 5-HT2AR agonists (mescaline, dimethyltryptamine) by indigenous cultures. A meta-analysis of randomized studies from several decades ago showed that administration of 5-HT2AR agonist lysergic acid diethylamide (LSD) in alcoholism treatment resulted in significantly less alcohol misuse than randomized control conditions, with a large effect size (odds ratio ~2). Research with 5-HT2AR agonist psilocybin in nonaddicted individuals shows effects suggestive of antiaddiction efficacy, including positive behavior change as assessed by experimentally blinded community observers, increased personality openness, and high ratings of personal meaning at long-term follow ups. In a recent open-label pilot study of psilocybin as an adjunct to cognitive behavioral smoking cessation therapy in 15 treatment-refractory participants, 80% showed biologically verified smoking abstinence at 6-month follow-up. Although not definitive, these results are substantially greater than typical treatments. Another recent pilot study suggested safety and efficacy of psilocybin as an adjunct to Motivational Enhancement Therapy for alcoholism. This presentation will review this research, describe ongoing randomized trials, and discuss potential behavioral mechanisms. |
Instruction Level: Intermediate |
Target Audience: Applied and basic behavior analysts interested in research on the use of hallucinogens in the treatment of addiction. |
Learning Objectives: 1) Participants will describe multiple lines of evidence suggesting potential efficacy of classic psychedelics in addictions treatment. 2) Participants will describe the results of a recent pilot study examining psilocybin in the treatment of tobacco addiction. 3) Participants will describe potential mechanisms by which psychechedelics may improve addiction treatment outcomes. |
|
MATTHEW W. JOHNSON (Johns Hopkins University School of Medicine) |
The underlying theme of Dr. Matthew Johnson's career has been to understand and facilitate human behavioral change, particularly behavioral change in addiction recovery. Toward that end, much of Dr. Johnson's research has applied behavioral economic concepts such as delay discounting and demand elasticity to decision making underlying addiction. His recent research has applied these models to understand the high rates of sexual HIV risk behavior associated with certain abused drugs (e.g., cocaine, methamphetamine, alcohol). This line of research has suggested that delay discounting is a critical but under-appreciated variable influencing sexual risk behavior. Another focus of Dr. Johnson's research involves laboratory studies determining the behavioral effects of psychoactive drugs in humans, including novel or atypical drugs. This work has examined psychedelics including psilocybin, dextromethorphan, and salvinorin A (from the plant Salvia divinorum), stimulants including cocaine, methamphetamine, nicotine, and caffeine, and various sedatives including GHB and alcohol. Current research with the psychedelic drug psilocybin is examining its potential for facilitating behavior change. These studies include a trial determining the ability of psilocybin to increase engagement in a meditation program, a trial testing if psilocybin can decrease anxiety and depression in cancer patients, and a study examining psilocybin as an anti-addiction medication for tobacco smoking cessation. |
Keyword(s): addiction treatment, cognitive behavioral, psilocybin, psychedelic |
|
|
|
|
Behavioral Activation as a Treatment for Adolescent Depression |
Monday, May 25, 2015 |
10:00 AM–10:50 AM |
Texas Ballroom Salon A (Grand Hyatt) |
Area: CBM; Domain: Service Delivery |
PSY/BACB CE Offered. CE Instructor: Steven R. Lawyer, Ph.D. |
Chair: Steven R. Lawyer (Idaho State University) |
Presenting Authors: : SCOTT T. GAYNOR (Western Michigan University) |
Abstract: From a behavioral perspective, depression is a summary label for a set of responses emitted in a context, not an internal (neurobiological or psychological) defect within a person. As such, depressive symptoms should be treatable by changing environment-behavior interactions and the context in which they occur. Behavioral activation (BA) is a well-developed approach to treating depressive symptoms in adults with an emerging literature for adolescents. The goal of BA is to promote contact with positive reinforcement by engaging clients in focused activation strategies to counter passive avoidance/withdrawal and to increase goal-directed and values-guided behavior. The tutorial will briefly review of major components of BA, including: (1) the rationale and model of depression; (2) mood and activity monitoring; (3) conducting a values assessment; and (4) scheduling pleasurable, mastery-related, and values-based activities. |
Instruction Level: Basic |
Target Audience: Anyone interesting in the seeing the application of behavior analysis to depression, a common mental health problem. Also attendees, particularly students, who may have broad applied interests. |
Learning Objectives: At the conclusion of the presentation, participants should be able to: (1) describe the BA rationale and model of treatment; (2) describe how to introduce mood and activity monitoring; (3) describe how to assess values; and (4) describe how to select and schedule relevant activities. |
|
SCOTT T. GAYNOR (Western Michigan University) |
Scott Gaynor received his Ph.D. in clinical psychology from the University of North Carolina at Greensboro, where he had the good fortune to be mentored in behavior analysis by Rick Shull and clinical behavior analysis by Scott Lawrence and Rosemery Nelson-Gray. He completed his clinical internship and a post-doc at the University of Pittsburgh Medical Center’s Western Psychiatric Institute and Clinic. The next stop was Western Michigan University where has been on the faculty for 13 years, serving as the co-director of clinical training for the past six years. His research and clinical interests focus on evaluating the efficacy and mechanisms of action of contemporary behavior therapies. |
Keyword(s): behavioral activation, depression |
|
|
|
|
It's a System!: The Essential Role of Behavior Analysis in Developmental Systems Theory |
Monday, May 25, 2015 |
11:00 AM–11:50 AM |
Texas Ballroom Salon A (Grand Hyatt) |
Area: DEV; Domain: Theory |
PSY/BACB CE Offered. CE Instructor: Susan M. Schneider, Ph.D. |
Chair: Martha Pelaez (Florida International University) |
Presenting Authors: : SUSAN M. SCHNEIDER (University of the Pacific) |
Abstract: Try to picture all that's known about biology and behavior: Genes, epigenetics, neurophysiology, operant and respondent principles, hormones, history ... and much more. Like other sciences, ours has always been part of a grand interdisciplinary effort, and the biobehavioral system is large and complex indeed. Developmental Systems Theory attempts to encompass everything, including the many complex, nonlinear interactions across all levels. The operant principles in which behavior analysts specialize have proved to be an important part of the empowering flexibility in the larger system. Our work on the benefits of enriched environments, the causes and treatments for autism spectrum disorders, the surprising flexibility of "instincts," and rehabilitation for victims of stroke and traumatic brain injury, to name a few examples, are all part of much larger efforts. In turn, system interactions are critical influences on our own work. Scientists always knew a better understanding of the full nature-and-nurture system would bring surprises, and this tutorial will show how the reality has exceeded expectations. |
Instruction Level: Basic |
Target Audience: Psychologists, behavior analysts, practitioners, and graduate students. |
Learning Objectives:
- To describe developmental systems theory. At the conclusion of the event, participants will be able to explain how DST encompasses the entire biobehavioral system, including many complex, nonlinear interactions across all levels.
- To show how operant and respondent behavior principles play a critical role in developmental systems theory. At the conclusion of the event, participants will be able to describe how behavior principles influence and are influenced by the other system variables.
- To show the philosophical similarities between behavior analysis and developmental systems theory, including for example anti-reductionism. At the conclusion of the event, participants will be able to describe these similarities. Participants will also be able to describe the value to behavior analysts of understanding and contributing to developmental systems theory.
|
|
SUSAN M. SCHNEIDER (University of the Pacific) |
Dr. Susan M. Schneider’s involvement in behavior analysis goes back to high school when she read Beyond Freedom & Dignity and wrote B. F. Skinner, never dreaming that he would reply. They corresponded throughout her master’s degree in mechanical engineering at Brown University, her engineering career, and her stint in the Peace Corps. At that point, Schneider bowed to the inevitable and switched careers, obtaining her Ph.D. in developmental psychology in 1989 from the University of Kansas. A research pioneer, she was the first to apply the generalized matching law to sequences and to demonstrate operant generalization and matching in neonates. Her publications also cover the history and philosophy of behavior analysis and the neglected method of sequential analysis. Schneider has championed the inclusive “developmental systems” approach to nature nurture relations, culminating in reviews in the Journal of Experimental Analysis of Behavior and The Behavior Analyst, and she has served on the editorial boards for both of those journals. Her book, The Science of Consequences: How They Affect Genes, Change the Brain, and Impact Our World, summarizes the field of operant behavior, its larger nature-nurture context, and its full range of applications. It earned a mention in the journal Nature, was a selection of the Scientific American Book Club, and won the 2015 Society for the Advancement of Behavior Analysis Award for Effective Presentation of Behavior Analysis in the Mass Media. |
Keyword(s): genetics, interdisciplinary work, nature-nurture, neurophysiology |
|
|
|
|
Science is Not All Mathematics, Nor All Logic, but it is Somewhat Beauty and Poetry* |
Monday, May 25, 2015 |
2:00 PM–2:50 PM |
Lila Cockrell Theatre (CC) |
Area: CSE/EDC; Domain: Theory |
PSY/BACB CE Offered. CE Instructor: Travis Thompson, Ph.D. |
Chair: Mark P. Alavosius (Prxis2LLC) |
Presenting Authors: : TRAVIS THOMPSON (University of Minnesota) |
Abstract: Throughout the Renaissance, the arts and science were both often practiced by women and men of scholarship of all sorts. The very notion of a "Renaissance Man or Woman," speaks to the idea that today we have somehow lost our way, and expect divergence not integration. It was more common than not, that scientists also were practitioners of some form of painting or artistic writing, and the converse. From Leonardo da Vinci to B.F. Skinner, the two have more often than not been interwoven. The notion that the two are separate endeavors emerged after the Renaissance when science and the humanities diverged, reaching its culmination during and after World War II when C.P. Snow presented his famous Rede Lecture, "Two Cultures." The arts are integral features that create the context within which our practices as research and applied behavior analysts are conducted. Artistic factors also are behavioral variables in our analysis of behavior. They are also uniquely effective in creating the context for socio-cultural conditional learning and discriminations. As we look about us, we are compelled to ask, "Why do artists create art?" "Why can people with severe disabilities often create stunning artistic products while being unable to speak an intelligible sentence?" "Why do so many of us feel artistic activities are uplifting and add a dimension to our lives that exceed those of our science, alone?" "How can the concepts of the arts and sciences be integrated to mutual benefit?" In today's discussion, Dr. Travis Thompson will explore the intrerplay of artistic activities and behavior analytic endeavors, where they intertwine and separate. *The title is from a comment by the first American woman astronomer, Maria Mitchell in the 19th century. |
Instruction Level: Basic |
Target Audience: Psychologists, behavior analysts, practitioners, and graduate students. |
Learning Objectives: At the conclusion of the presentation, participants should be able to answer: Why do artists create art? (2) Why can people with severe disabilities often create stunning artistic products while being unable to speak an intelligible sentence? (3) Why do so many of us feel artistic activities are uplifting and add a dimension to our lives that exceed those of our science, alone? and (4) How can the concepts of the arts and sciences be integrated to mutual benefit? |
|
TRAVIS THOMPSON (University of Minnesota) |
Travis Thompson is professor of educational psychology and emeritus professor of psychology at the University of Minnesota, a Fellow of the ABAI, and recipient of the Society for the Advancement of Behavior Analysis Award for Impact of Science on Application. He has been a member of the ABAI Executive Council, distinguished scientist, clinical practitioner, author and lesser known, a visual artist and poet. He previously designed and constructed stained glass, has written essays on art glass, does watercolor paintings and writes engaging poetry. Among behavior analytic scientists he is one of the more effective in expressing the humanity of our science. His is the author or editor of 238 articles and chapters and 34 books, several written for practitioners and parents of children with autism. He is known to be especially effective in communicating with nonscientists about the importance of our work. He is the ABAI coordinator of the Behavior Analysis and the Arts Special Interest Group. |
|
|